RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases. As of December 31, 2018, it operated 11 hospitals and 5,369 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.
Industry, Sector and Symbol
Industry Medical Care
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone49 9771 65 0
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees9,384
Next Earnings DateN/A
OptionableNot Optionable
RHOEN-KLINIKUM/ADR (OTCMKTS:RKAGY) Frequently Asked Questions
What is RHOEN-KLINIKUM/ADR's stock symbol?
RHOEN-KLINIKUM/ADR trades on the OTCMKTS under the ticker symbol "RKAGY."
Has RHOEN-KLINIKUM/ADR been receiving favorable news coverage?
News articles about RKAGY stock have trended very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. RHOEN-KLINIKUM/ADR earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for RHOEN-KLINIKUM/ADR.
Who are some of RHOEN-KLINIKUM/ADR's key competitors?
Who are RHOEN-KLINIKUM/ADR's key executives?
RHOEN-KLINIKUM/ADR's management team includes the folowing people:
- Mr. Stephan Holzinger, Chairman of Board of Management & CEO
- Prof. Bernd Griewing, Chief Medical Officer & Member of Board of Management
- Dr. Gunther Karl Weiß, COO & Member of Management Board (Age 53)
- Mr. Jörg Demmler, Head of Technical Controlling & Environment (Age 67)
- Julian Schmitt, Head of Investor Relation
How do I buy shares of RHOEN-KLINIKUM/ADR?
Shares of RKAGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is RHOEN-KLINIKUM/ADR's stock price today?
One share of RKAGY stock can currently be purchased for approximately $8.95.
What is RHOEN-KLINIKUM/ADR's official website?
How can I contact RHOEN-KLINIKUM/ADR?
The company can be reached via phone at 49 9771 65 0.
MarketBeat Community Rating for RHOEN-KLINIKUM/ADR (OTCMKTS RKAGY)
MarketBeat's community ratings are surveys of what our community members think about RHOEN-KLINIKUM/ADR and other stocks. Vote "Outperform" if you believe RKAGY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RKAGY will underperform the S&P 500 over the long term. You may vote once every thirty days.
